Brassinin Exhibits Anti-Diabetic Activity against Streptozotocin-induced Diabetes Mellitus in Experimental Rats
1, 2, 2, 3, 4, 5
- 1Teaching and Research Section of Internal Medicine, Zhaoqing Medical College, Guangdong Province, CHINA.
- 2Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, SAUDI ARABIA.
- 3Department of Cellular and Molecular Biology, University of Texas at Tyler Health Science Center, Tyler, TEXAS, USA.
- 4Faculty of Medicine, Bioscience and Nursing, Mahsa University, Saujana Putra, MALAYSIA.
- 5Department of Chemistry, Faculty of Science, Isra University, Amman, JORDAN.
CORRESPONDENCE
Dr. Bixia Xu
Teaching and Research Section of Internal Medicine, Zhaoqing Medical College, Zhaoqing City, Guangdong Province, 526020, CHINA.
Received: 01-01-2023; Accepted: 01-07-2023.
Volume 57, Issue 3s (Supplement) · pp. s701-s709 · 2023 · DOI: 10.5530/ijper.57.3s.79
ABSTRACT
Background: Diabetes mellitus is among the most serious public health problems worldwide.Materials and Methods: 35mg/kg STZ was injected to rats for stimulating diabetes. Then rats were treated with 25mg/kg of brassinin.Results: Brassinin and Glibenclamide remarkably decreased glucose and HbA1c levels in diabetic rats, while insulin levels were elevated. They also increased antioxidant enzymes and decreased inflammatory markers.Conclusion: Brassinin is an antihyperglycemic, antioxidant, and anti-inflammatory compound that protects the liver, kidney, and pancreas during diabetes.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Xu, B., Alarfaj, A. A., Hirad, A. H., Natarajan, N., Iyappan, P., & Ali, S. H. H. A. (2023). Brassinin Exhibits Anti-Diabetic Activity against Streptozotocin-induced Diabetes Mellitus in Experimental Rats. Indian Journal of Pharmaceutical Education and Research, 57(3s), s701-s709. https://doi.org/10.5530/ijper.57.3s.79
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0
